Rubius Therapeutics Inc.

NASDAQ: RUBY · Real-Time Price · USD
0.06
0.00 (8.11%)
At close: Dec 29, 2023, 9:49 PM

Rubius Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.07 -4.51
PEG Ratio
-0.00 -0.65
PS Ratio
n/a n/a
PB Ratio
1.04 4.76
P/FCF Ratio
-0.1 -5.72
P/OCF Ratio
-0.11 -5.87
OCF/S Ratio
n/a n/a
Debt / Equity Ratio
0.07 0.63
Quick Ratio
2.54 6.63
Current Ratio
2.54 6.63
Asset Turnover
n/a n/a
Interest Coverage
-46.19 -30.25
Return on Equity
-15.26 -1.06
Return on Assets
-10.01 -0.59
Return on Invested Capital
-14.13 -0.64
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
n/a n/a
Net Profit Margin
n/a n/a
Pretax Profit Margin
n/a n/a
Operating Profit Margin
n/a n/a
FCF Margin
n/a n/a
EBITDA Margin
n/a n/a